Literature DB >> 7886662

Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease.

P Jolliet1, J B Thorens, J C Chevrolet.   

Abstract

Pulmonary vascular reactivity tests were performed in a young woman with mixed connective tissue disease and severe pulmonary hypertension. Vasoreactivity was documented in response to intravenous prostacyclin (PGI2), oral nifedipine, and inhaled nitric oxide, with quantitative differences. Nitric oxide produced a moderate lowering of pulmonary arterial pressure and resistance without any deleterious systemic effect. The use of nitric oxide in testing for pulmonary vasoreactivity merits further evaluation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7886662      PMCID: PMC473731          DOI: 10.1136/thx.50.1.96

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Death in a patient with primary pulmonary hypertension after 20 mg of nifedipine.

Authors:  J Partanen; M S Nieminen; K Luomanmäki
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

3.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

4.  Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.

Authors:  M Dahl; A Chalmers; J Wade; D Calverley; B Munt
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

5.  Pulmonary vascular overreactivity in systemic hypertension. A pathophysiological link between the greater and the lesser circulation.

Authors:  C Fiorentini; P Barbier; C Galli; A Loaldi; G Tamborini; E Tosi; M D Guazzi
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

  5 in total
  1 in total

Review 1.  Treatment of pulmonary hypertension secondary to connective tissue diseases.

Authors:  O Sanchez; M Humbert; O Sitbon; G Simonneau
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.